4//SEC Filing
Lenington Rachel 4
Accession 0001209191-22-004129
CIK 0001620463other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 5:31 PM ET
Size
5.5 KB
Accession
0001209191-22-004129
Insider Transaction Report
Form 4
Lenington Rachel
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-18+180,000→ 180,000 totalExercise: $10.64Exp: 2032-01-17→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001861194
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 5:31 PM ET
- Size
- 5.5 KB